The Recall Desk
ModerateFDA (Drugs)·D-0580-2020·Announced 2019-12-18

Anazao Health Recalls Clonidine and Hydromorphone Due to Fungal Contamination

Anazao Health is recalling Clonidine HCL/Hydromorphone HCL products because environmental sampling detected Talaromyces rotundus, a fungus, indicating a lack of processing controls.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, but the source text does not report any illnesses, injuries, or hospitalizations. The hazard is a theoretical risk of fungal contamination without confirmed adverse health consequences, fitting the criteria for a moderate severity score.

Plain-English summary

Coast Quality Pharmacy, LLC dba Anazao Health is recalling Clonidine HCL/Hydromorphone HCL in all strengths, doses, and packaging. The recall is due to a lack of processing controls, as environmental sampling revealed the presence of Talaromyces rotundus, a type of fungus.

The affected products were filled and dispensed between August 26, 2019, and August 29, 2019, and between September 27, 2019, and October 3, 2019, provided they remain within their expiration dates. The products were distributed nationwide in the United States.

Consumers should stop using the recalled products and contact their healthcare provider or pharmacist for guidance on alternative treatments or disposal.

The recalled product

Product
Clonidine HCL/Hydromorphone HCL in all strengths, all doses and all packaging, AnazaoHealth 5710 Hoover Blvd Tampa, FL 33634.

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 31 recalled by Coast Quality Pharmacy, LLC dba Anazao Health under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 31 products in this recall →